|HUM-MOLGEN -> Events -> Meetings and Conferences|
|IBC's Formulation Strategies for Biopharmaceuticals|
|May 21, 2003|
IBC Life Sciences, Wyndham Philadelphia Hotel, Philadelphia, PA
September 22-24, 2003
Attend IBC’s Formulation Strategies for Biopharmaceuticals conference to obtain the solutions to your most pressing problems in developing formulations for protein & peptide therapeutics. Specifically, you will learn from leaders in industry and academia with new reports on protein stability, therapeutic specific formulations, practical issues involving analytical methods and process scale-up, as well as the potential for using protein engineering to improve stability profiles. Plus, for the first time, the Formulations meeting will be co-located with IBC’s Protein & Peptide Drug Delivery – expanding your networking opportunities and giving you the opportunity to attends sessions for this conference when you register for Formulations.
|Organized by:||IBC Life Sciences|
|Invited Speakers:||Keynote Presentations:
John Carpenter, Ph.D., Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado
Steven J. Shire, Ph.D., Senior Scientist/Group Leader, Pharmaceutical R&D, Genentech, Inc.
|Deadline for Abstracts:||-`|
|Registration:||Phone (508) 616-5550 x1004 Fax (508) 616-5522+ Email email@example.com Online www.LifeSciencesInfo.com/formulations|
|Posted by:||James G. Prudhomme|